From Antibodies To Vaccines: How Prestige BioPharma Is Shaping Its Future
Asia Axes In Korea, Singapore
Executive Summary
The vice-chairman of Singapore-based Prestige Group talks to Scrip about the biopharma's strategies in Asia and elsewhere, as it focuses on vaccines for COVID-19 and other diseases, along with novel antibody therapeutics in oncology and biosimilars.